Transfusion Therapy Articles & Analysis
3 news found
Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. ...
Responsibility to our donors and patients Grifols continues to reinforce its long-term commitment to its donors in light of their critical role in the manufacture of plasma-derived therapies. Grifols’ plasma centers, production and commercial facilities remain operational, making possible continued production and supply of plasma-derived medicines, diagnostic and hospital ...
Grifols today announces that it has entered into a formal collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical ...